Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · AGARWALEYE

AGARWALEYE

HealthcareHealthcare Services₹17421 cr market cap
₹553.10 ▲ +0.66% today As of 19 Nov 2026
52-week low ₹406.5552-week high ₹560.70

-2.0% from the 52-week high · +35.2% above the low

Dr Agarwal's Health Care Ltd provides ophthalmic care, diagnostic services, and medical treatments. The company operates a network of clinics, focusing on patient care, accessibility, and advanced eye health solutions.

The short version. AGARWALEYE reported revenue of ₹655 crore for Sep 2026, up 31.3% from a year earlier. Net profit was ₹55 crore (up 83.3% year on year). Return on equity was 6.6% in Mar 2026. Promoter holding was 32.33% in Sep 2026, down 0.12 points over 8 quarters.

1 · The price

How has the stock traded?

AGARWALEYE trades 2.0% below its 52-week high and 35.2% above its 52-week low.

Change over period: —

1M+17.3%
3M+9.5%
6M+19.5%
1Y+8.5%

2 · The business

Is it growing?

Sales, year on year+31.3%

Sep 2026 revenue of ₹655 cr.

Profit, year on year+83.3%

Sep 2026 net profit of ₹55 cr.

Net margin8.4%

2.4 pts higher than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue655614564530499487460431
Net profit5545403430303322
Net margin %8.47.47.06.46.06.27.15.2
EPS (₹)1.731.431.251.070.940.951.030.71

Annual

FY2026FY2025
Revenue20801711
Net profit13383
Net margin %6.44.9
EPS (₹)4.22.64

3 · The quality

How well does it turn capital into profit?

Return on equity was 6.6% in Mar 2026; debt to equity is 0.08.

Profitability · 2 years

Returns and margins

Mar 2026Mar 2025
Return on equity %6.64.5
Return on capital %9.78.4
EBITDA margin %29.028.4
Net margin %6.34.8

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.08
Interest cover3.8x
Current ratio1.24
P/E ratio102.9

4 · The owners

Who holds it, and are they adding?

Promoter holding32.33%

Down 0.12 pts over 8 quarters.

Foreign institutions49.56%

Down 7.41 pts over 8 quarters.

Domestic institutions15.87%

Up 10.77 pts over 8 quarters.

Mutual fund schemes41

+5 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter32.4532.4532.4232.4232.3932.3632.3432.33-0.12
FII56.9760.6259.2658.1358.0657.9457.9649.56-7.41
DII5.15.216.447.927.787.837.7215.87+10.77
Public5.491.721.881.521.771.871.982.24-3.25

Mutual fund holdings · Oct 2026

41 schemes hold this stock

36 the month before.

  • Invesco India Pharma and Healthcare Fund7.93% of NAV
  • MOTILAL OSWAL SMALL CAP FUND3.33% of NAV
  • Invesco India Consumption Fund2.99% of NAV
  • ICICI Prudential Healthcare Fund2.77% of NAV
  • LIC MF HEALTHCARE FUND2.69% of NAV
  • Invesco India Multi cap Fund2.42% of NAV
  • Invesco India Small cap Fund2.38% of NAV
  • LIC MF SMALL CAP FUND1.9% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for AGARWALEYE are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about AGARWALEYE

What is the AGARWALEYE share price?

AGARWALEYE (AGARWALEYE) last closed at ₹553.10, up 0.66% on the day. Its 52-week range is ₹406.55 to ₹560.70.

What is the market cap of AGARWALEYE?

AGARWALEYE has a market capitalisation of about ₹17,421 crore. Its price-to-earnings ratio is 102.9.

How are AGARWALEYE's latest results?

AGARWALEYE reported revenue of ₹655 crore for Sep 2026, up 31.3% from a year earlier. Net profit was ₹55 crore (up 83.3% year on year). Return on equity was 6.6% in Mar 2026. Promoter holding was 32.33% in Sep 2026, down 0.12 points over 8 quarters.

Who owns AGARWALEYE?

As of Sep 2026, shareholding was: Promoter 32.33%, FII 49.56%, DII 15.87%, Public 2.24%.

How many mutual funds hold AGARWALEYE?

41 mutual fund schemes held AGARWALEYE in October 2026. That compares with 36 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.